Interaction of HIF1α with heat shock proteins HSP90 and HSP70 in the cerebral cortex during hypoxia
Abstract
The aim of the study was to investigate the dynamics of expression of HIF1α, HSP90 and HSP70 in the cerebral cortex (CC) of rats with genetically determined differences in tolerance to oxygen shortage in hypobaric hypoxia of different severity, duration and multiplicity. Methods. The study was conducted on white mongrel male rats, divided into groups by sensitivity to acute hypobaric hypoxia (3% O₂, 190 mm Hg, 11.5 km). Hypobaric hypoxia (HBH) of different severity was modeled in a flow-type altitude chamber. The pressure in the chamber simulated “altitudes” of 3,000 m (14% O₂, 526 mm Hg), 5,000 m (10% O₂, 380 mm Hg), and 7,000 m (8% O₂, 290 mm Hg). Duration of a single exposure varied from 15 min to 4 h (15, 30, 45, 60 min, 2, and 4 h), and each exposure in an HBH course (daily sessions, 20 days) lasted for 60 min. Contents of HSP90 and HSP70 were measured in the CC cytoplasmic extract and content of HIF1α — in the CC nuclear extract using Western blotting. Results. The study showed for the first time that the baseline expression of HIF1α and HSP90 in normoxia was higher in CC of hypoxia low-resistance (LR) rats than in high-resistance rats, which indicated a high significance of HIF1α-HSP90-dependent mechanisms in maintaining CC oxygen homeostasis in LR rats under normal physiological conditions. In hypoxia of different severity and duration, the pattern of urgent expression of HSP90 and HIF1α changed from induction in mild (14% O₂, 526 mm Hg) and moderate (10% O₂, 380 mm Hg) hypoxia to suppression in severe hypoxia (8% O₂, 290 mm Hg). During the course of repeated, non-damaging hypoxia (10% O₂/14% O₂, 60 min, 20 days), a progressive increase in the content of HIF1α was associated with depressed expression of HSP90 and HSP70, which suggested a possible negative regulation by HIF1. Studying changes in HIF1α, HSP90 and HSP70 expression during single and repeated exposures to non-damaging hypoxia suggested that short courses (3—8 days) of moderate 60-min hypoxic exposures could be used to induce HIF1α-HSP90-dependent adaptive mechanisms. Repeated severe hypoxia caused a steady suppression of HSP90, HSP70 and HIF1α expression and failure of HIF1α-HSP90-dependent mechanisms of adaptation to oxygen deficiency. Conclusion. Using different modes of hypobaric hypoxia is a potential approach to modulation of HIF1α-HSP90 complex stability and effectiveness of HIF1-dependent mechanisms of adaptation to oxygen deficiency.
Downloads
References
2. Zhao R., Houry W.A. Hsp90: a chaperone for protein folding and gene regulation. Biochem. Cell Biol. 2005; 83: 703-10.
3. Zhou J., Schmid T., Frank R., Brune B. PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1{alpha} from pVHL-independent degradation. J Biol Chem. 2004; 279: 13506-13.
4. Liu Y.V., Baek J.H., Zhang H., Diez R., Cole R.N., Semenza G.L. RACK1 competes with HSP90 for binding to HIF-1a and is required for O2-independent and HSP90 inhibitor-induced degradation of HIF-1a. Mol. Cell. 2007; 25(2): 207-17.
5. Beck R., Dejeans N., Glorieux C., Pedrosa R.C., Vasquez D., Valderrama J.A. et al. Molecular chaperone Hsp90 as a target for oxidant-based anticancer therapies. Curr Med Chem. 2011; 18(18): 2816-25.
6. Malyshev I.Ju. Hypoxia and reprogramming of the immune response in tumor development: the central role of macrophages. Patogenez. 2011; 3: 44-5. (in Russian)
7. Muller P., Ruckova E., Halada P., Coates P.J., Hrstka R., Lane D.P. et al. C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances. Oncogene. 2012; 32: 3101-10.
8. Shih Y., Chun-Hung L. S-Glutathionylation promotes HSP90 degradation under oxidative stress. The FASEB. 2015; 29(1). Supplement 717.6.
9. Lukyanova L.D., Germanova Je.L., Kopaladze R.A. Patterns of formation of resistance of the organism under different regimes of hypoxic preconditioning: the role of the hypoxic period and reoxygenation. Bulleten’ eksperimental’noy biologii i meditsiny. 2009; 147(4): 380-4. (in Russian)
10. Zhang X., Huang C.J., Nazarian R., Ritchie T., de Vellis J.S., Noble E.P. Isolation of nuclear protein from human brain. Bio Thechniques. 1997; 22(5): 848-50.
11. Shahbazian F.M., Jacobs M., Laitha A. Rates of protein synthesis in brain and other organs. Int J Dev Neurosci.1987; 5(1): 39-42.
12. Kirova Yu.I. The role of the glutathione system in theregulation of the oxidation-reduction status of the rat cerebral cortex during hypoxia. Patologicheskaya fiziologiya i eksperimental’naya terapiya. 2014; 4: 40-7. (in Russian)
13. Shurygina L.V., Zlischeva E.I., Kravtsov A.A., Poleshchuk L.A., Abramova N.O. Effect of potassium comenateon antioxidant glutathione system in brain of stressed mice.Patologicheskaya fiziologiya i eksperimental’naya terapiya.2016; 60(2): 20-3. (in Russian)
14. Cummins E.P., Berra E., Comerford K.M., Ginouves A., Fitzgerald K.T., Seeballuck F. et al. Prolyl hydroxylase-1 negatively regulates IkB kinase-b, giving insight into hypoxia-induced NFkB activity. Proc. Natl. Acad. Sci. U.S.A.2006; 103: 18154-59.
15. Prodromou C. Mechanisms of Hsp90 regulation. Biochem. J. 2016; 473: 2439-52.
16. Gorlach A., Bonello S. The cross-talk betweenNF-kB and HIF-1: further evidence for a significant liaison.Biochem. J. 2008; 412: e17-9.
17. Ammirante M., Rosati A., Gentilella A., Festa M.,Petrella A., Marzullo L. et al. The activity of hsp90 alphapromoter is regulated by NF-kappa B transcription factors.Oncogen. 2008; 27(8): 1175-8.
18. Lukyanova L.D., Kirova Yu.I. Mitochondria-controlled signaling mechanisms of brain protection in hypoxia.Frontiers in Neuroscience. 2015; 9: 1-15.
19. Kirova Yu.I., Lukyanova L.D. Regulatory role of the glutathione system in coupled redox processes of brain adaptation to hypoxia. In: Y. Kawai, A.R. Hargens, P.K. Singal. Adaptation Biology and Medicine. Current Trends. Narosa Publishing House Pvt. Ltd., New Delhi, India. 2017; 8: 221-40.
20. Kundrat L., Lynne R. Identification of residues on Hsp70 and Hsp90 ubiquitinated by the co-chaperone CHIP. J Mol Biol. 2010; 395(3): 587-94.
21. Shi H. Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke. Curr Med Chem. 2009; 16(34): 4593-600.
22. Taylor D.M., Tradewell M.L., Minotti S., Durham H.D. Characterizing the role of Hsp90 in production of heat shock proteins in motor neurons reveals a suppressive effect of wild-type Hsf1. Cell Stress & Chaperones. 2007; 12(2): 151-62.
23. Gogate S.S., Fujita N., Skubutyte R., Shapiro I.M., Risbud M.V. TonEBP and HIF coordinate Hsp70 expression in hypoxic nucleus pulposus cells: role of Hsp70 in HIF-1a degradation. J Bone Miner Res. 2012; 27(5): 1106-17.
